Novartis
NVS
$97.86
Share price
-1.21%
Change (1 day)
-5.94%
Change (1 year)
Categories
Novartis AG is a biotechnology and pharmaceutical company based in Basel, Switzerland. Novartis was formed in 1996 from a merger of the two Basel pharmaceutical and chemical companies Ciba-Geigy AG and Sandoz AG. Novartis is one of the largest pharmaceutical companies in the world with sales of USD 47.4 billion in 2019.
Novartis (NVS) - Total assets
Total assets on the balance sheet as of December 2023 : $99.94 B
According to Novartis's latest financial reports the company's total assets are $99.94 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Novartis - Total assets on balance sheet (from 2001 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $99.94 B | -14.91% |
| 2022-12-31 | $117.45 B | -10.88% |
| 2021-12-31 | $131.79 B | 3.14% |
| 2020-12-31 | $127.77 B | 7.95% |
| 2019-12-31 | $118.37 B | -18.68% |
| 2018-12-31 | $145.56 B | 9.38% |
| 2017-12-31 | $133.07 B | 2.27% |
| 2016-12-31 | $130.12 B | -1.09% |
| 2015-12-31 | $131.55 B | 4.92% |
| 2014-12-31 | $125.38 B | -0.69% |
| 2013-12-31 | $126.25 B | 1.66% |
| 2012-12-31 | $124.19 B | 5.7% |
| 2011-12-31 | $117.49 B | -4.72% |
| 2010-12-31 | $123.31 B | 29.12% |
| 2009-12-31 | $95.50 B | 21.97% |
| 2008-12-31 | $78.29 B | 3.77% |
| 2007-12-31 | $75.45 B | 10.95% |
| 2006-12-31 | $68.00 B | 17.8% |
| 2005-12-31 | $57.73 B | 9.99% |
| 2004-12-31 | $52.48 B | 6.43% |
| 2003-12-31 | $49.31 B | 9.53% |
| 2002-12-31 | $45.02 B | 11.71% |
| 2001-12-31 | $40.30 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $167.55 B | 67.65% | 🇺🇸 USA |
 Pfizer PFE | $226.50 B | 126.63% | 🇺🇸 USA |
 Abbott Laboratories ABT | $73.21 B | -26.75% | 🇺🇸 USA |
 Sanofi SNY | $139.81 B | 39.89% | 🇫🇷 France |
 Merck MRK | $106.67 B | 6.73% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $95.15 B | -4.79% | 🇺🇸 USA |
 AstraZeneca AZN | $101.11 B | 1.17% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $75.11 B | -24.85% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $43.47 B | -56.50% | 🇮🇱 Israel |